Main > ONCOLOGY (**) > Colon Cancer>Dukes C (Stage III) * > Adjuvant > Co: CH. R. Brand Capecitabine Tab.

---

Co: CH. R. Brand Capecitabine Tab.'s subsections
(*) USA Approval Date: 1998. 04.30
Company
Nucleoside Metabolic Inhibitor
Patent>Expiration Date: 2011. 01.13
ProDrug>Converts to 5-F Uracil
TradeMark
TradeMark Web-Site

Co: CH. R. Brand Capecitabine Tab.'s products
This section has no products